News

Revolade is an oral treatment that stimulates the production of blood platelets, which are essential to normal clotting. GSK claimed that the anti-allergic drug, Xyzal, has been approved

Metoprolol Tartrate injection, USP is the generic equivalent of Lopressor, which is marketed by Novartis International, and is used in the treatment of acute myocardial infarction (AMI). APP

Nexium is indicated for the treatment of gastroesophageal reflux disease. As per the terms of the agreement, AstraZeneca and Daiichi Sankyo will co-promote the product after it is

Taro Pharma has posted a net income of $18.86m for the third quarter 2010, or $0.46 per diluted share, compared to $9.73m, or $0.24 per diluted share, for

BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, and clinical supply chain design and

The cobas e 602 module, which uses Roche’s patented electrochemiluminescence (ECL) technology, includes more than 50 assays on its initial test menu and offers a throughput of up

Novartis said that the agreement is an extension to the existing relationship with Adesso Solutions and confirms they will continue to provide trade planning and execution, check request

In the trial, the improvement in FEV1, the primary endpoint, was prominent in the 200ug (p=0.019) and 400ug (p=0.001) BID dose groups. However, for the expected therapeutic dose,

Degarelix is a gonadtrophin-releasing hormone (GnRH) blocker with a subcutaneously injectable formulation. In January 2006, Astellas and Ferring International Center entered into a license agreement that gives Astellas